“…It located in the SH3 domain of MAP3K21, which was responsible for controlling or regulating protein-protein interactions in the signal transduction pathways, such as cytoplasmic signaling (Koch, Anderson, Moran, Ellis, & Pawson, 1991;Schlessinger, 1994). MAP3K21 is a member of the mixed lineage kinases family that acts as a specific modulator to inhibit lipopolysaccharide (LPS)-induced activation of c-Jun N-terminal kinase (JNK), or extracellular signal-regulated kinase (ERK) (Craige, Reif, & Kant, 2016), or as a negative regulator of Tolllike receptor 4 (TLR4) signaling (Seit-Nebi, Cheng, Xu, & Han, 2012). It's well known that JNK, ERK, and TLR4 are all implicated with obesity through elevating gene expression level (Ahmad et al, 2012;Hirosumi et al, 2002), promoting insulin resistance (Hirosumi et al, 2002;Ozaki et al, 2016;Pal et al, 2012;Solinas & Becattini, 2017), or stimulating adipogenic differentiation (Gu et al, 2015).…”